首页> 中文期刊>医学综述 >肝星形细胞凋亡机制的最新进展

肝星形细胞凋亡机制的最新进展

     

摘要

Chronic liver disease is a major rause oi death around the world, Chronir liver injury caused by various kinds oi pathogenie iartors ran lead to liver iibrosis. Emerging experimental and rliniral evidence is stalling to show that liver iibrosis even early cirrhosis is potentially reversible. Key to this is the discovery that reversion oi iibrosis is accompanied by oi hepatic stellate cell( HSC )apoptosis. So, Clarifying the mechanism oi HSC apoptosis is an important way to develop new antifibrosis medicine. Apoptosis oi HSC are regulated by many iartors, including rytokines and its receptors, natural kill cells, extracellular matrix, neuroendo-crine signaling,pharmacological agents and post-translational modification. Here is to make a review on the related iactors.%慢性肝病是全球重要死因之一,各种致病因素所致慢性肝损伤均可引起肝纤维化.近年来临床和实验数据均显示肝纤维化甚至肝硬化均可通过肝星形细胞(HSC)的凋亡而得以逆转,因此,阐明肝星形细胞凋亡的分子机制成为发展抗纤维化药物的重要途径之一.肝星形细胞的凋亡受多种因素调控,包括生长因子及其受体、自然杀伤细胞、细胞外基质组分、神经内分泌通路、药物制剂以及翻译后修饰均可影响肝星形细胞的凋亡.在此就各相关因素进行综述.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号